Literature DB >> 10486686

Intraoperative complications of perfluoroperhydrophenanthrene: subretinal perfluorocarbon, retinal slippage and residual perfluorocarbon. Vitreon Study Group.

S Meffert1, G A Peyman.   

Abstract

BACKGROUND: An earlier analysis of postoperative complications of the perfluorocarbon liquid perfluoroperhydrophenanthrene (Vitreon) showed a low overall rate of posterior segment complications. A study was conducted to determine the incidence of specific intraoperative complications in a wide variety of vitreoretinal procedures performed by many different surgeons using Vitreon.
METHODS: The records of consecutive patients enrolled in the Vitreon Collaborative Study were reviewed to determine the incidence of subretinal Vitreon, retinal slippage and residual Vitreon. A total of 1867 vitreoretinal procedures performed between Nov. 16, 1989, and Dec. 14, 1994, at 35 participating centres were studied. Vitreon was used as a surgical tool at the surgeon's discretion after informed consent was obtained. The incidence of intraoperative complications was determined, and preoperative, intraoperative and postoperative characteristics were tabulated.
RESULTS: Subretinal Vitreon was observed in 24 patients (1.3%), retinal slippage in 20 patients (1.1%) (15 [6.9%] of the 216 patients with giant retinal tears) and residual Vitreon in 68 patients (3.6%).
INTERPRETATION: Vitreon can be used as a surgical tool in a wide variety of vitreoretinal procedures with a low incidence of intraoperative complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486686

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  2 in total

1.  Avoiding retinal slippage during macular translocation surgery with 360 retinotomy.

Authors:  Kenneth K W Li; David Wong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-11-15       Impact factor: 3.117

2.  Unprompted Closure of Spontaneous Macular Hole Secondary to Retained Subfoveal Perfluorocarbon Liquid.

Authors:  Hamouda Hamdy Ghoraba; Hashem Hamouda Ghoraba; Adel Galal Zaky
Journal:  Case Rep Ophthalmol Med       Date:  2022-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.